Literature DB >> 10553113

Aniseikonia in relation to strabismus, anisometropia and amblyopia.

V Lubkin1, P Kramer, D Meininger, S Shippman, G Bennett, P Visintainer.   

Abstract

PURPOSE: To study the interrelationships among these four entities which are critical to binocular vision and its precision. SUBJECTS AND METHODS: 102 selected patients (for their ability to have stereoscopic depth perception, a requisite for space eikonometry) were evaluated. Patient testing included stereoscopic testing, Essilor Projection Space Eikonometry, ultrasonic echographic axial length measurements and orthoptic evaluation. Aniseikonia was measured on the Essilor Projection Space Eikonometer.
RESULTS: 1. Anisometropia alone was correlated with a marked increase in amblyopia, a moderate increase in aniseikonia and no noteworthy increase in strabismus. Statistical analysis (chi square ratio) showed that persons with elevated anisometropic values had a 4.4 fold increased risk of aniseikonia (p=.003). 2. Aniseikonia alone was not responsible for marked variations in strabismus. 3. Amblyopia was correlated with increases in anisometropia and aniseikonia. 4. Adding aniseikonia to anisometropia produced a possible increase in strabismus and a great increase in amblyopia (using Fisher's Exact Test, 2-tailed). 5. Spearman correlations of the "absolute values" (the mean of the mathematical difference between the two eyes of anisometropia and amblyopia) were as follows: anisometropia (abs) vs. aniseikonia r=.294, p=.006; anisometropia (abs) vs. amblyopia (abs) 4=.555, p=<.001; amblyopia (abs) vs. aniseikonia r=.234, p=.02.
CONCLUSIONS: Aniseikonia per se does not appear to have a major causal role in amblyopia or strabismus, but anisometropia does for amblyopia. This role is greatly augmented by aniseikonia and this combination may then produce strabismus.

Entities:  

Mesh:

Year:  1999        PMID: 10553113

Source DB:  PubMed          Journal:  Binocul Vis Strabismus Q        ISSN: 1088-6281


  8 in total

1.  Femtosecond laser corneal refractive surgery for the correction of high myopic anisometropic amblyopia in juveniles.

Authors:  Jing Zhang; Ke-Ming Yu
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

2.  Aniseikonia associated with epiretinal membranes.

Authors:  M Ugarte; T H Williamson
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Phakic posterior chamber intraocular lens for unilateral high myopic amblyopia in Chinese pediatric patients.

Authors:  Jing Zhang; Jin-Rong Li; Zi-Dong Chen; Min-Bin Yu; Ke-Ming Yu
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

4.  Stereoacuity in children with anisometropic amblyopia.

Authors:  David K Wallace; Elizabeth L Lazar; Michele Melia; Eileen E Birch; Jonathan M Holmes; Kristine B Hopkins; Raymond T Kraker; Marjean T Kulp; Yi Pang; Michael X Repka; Susanna M Tamkins; Katherine K Weise
Journal:  J AAPOS       Date:  2011-10       Impact factor: 1.220

5.  Stereopsis after successful surgery for rhegmatogenous retinal detachment.

Authors:  Hiroki Watanabe; Fumiki Okamoto; Yoshimi Sugiura; Sujin Hoshi; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-26       Impact factor: 3.117

6.  Phakic anterior chamber intraocular lens (Verisyse) implantation in children for treatment of severe ansiometropia myopia and amblyopia: Six-month pilot clincial trial and review of literature.

Authors:  Amir Pirouzian; Kenneth C Ip; Henry S O'Halloran
Journal:  Clin Ophthalmol       Date:  2009-06-29

7.  Clinical Aniseikonia in Anisometropia and Amblyopia.

Authors:  Jayshree South; Tina Gao; Andrew Collins; Arier Lee; Jason Turuwhenua; Joanna Black
Journal:  Br Ir Orthopt J       Date:  2020-11-20

8.  The relationship between clinical measures of aniseikonia and stereoacuity before and after LASIK.

Authors:  Ivana Mravicic; Maja Bohac; Selma Lukacevic; Kruno Jagaric; Merlak Maja; Sudi Patel
Journal:  J Optom       Date:  2019-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.